Mesut AYDIN, Ahmet cumhur DÜLGER, Serhat ÖZER, Yaren DİRİK, Sıddık KESKİN, Canan DEMİR

Gastrıc Intestınal Metaplasıa and Covıd 19 Infectıon

Gastric intestinal metaplasia (GIM) is defined as immigration of enteric or colonic mucosa within gastric lining.Gastric intestinal metaplasia (GIM) is a premalign condition seen in gastric lining. It is prevalent in Asia and may lead to gastric carcinoma at a rate of 1% annually. COVID 19, which has been a global issue since late 2019, causes mostly respiratory symptoms; however, some patients may present with gastrointestinal symptoms including diarrhea, vomiting (5%) and abdominal pain ( 3.8%).We tried in this text to handle any possible association between COVID 19 infection and GIM. In this retrospective study we included 39 COVID 19 patients and 180 age-matched control subjects to compare rate of intestinal metaplasia. All statistical analyses were performed with SAS software (SAS Institute, Cary, N.C.). The clinical and radiological characteristics of patients were compared using Student's t-test. Intestinal metaplasia was found in 11 (28%) of 39 patients while in 7 (3,9%) of 181 controls, which meant a statistical significance (p0,05). We found that GIM is a premalignant condition that can lead to COVID 19 infection

PDF

___

1. Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer 2017; 17: 594-604.

2. Rugge M, Sugano K, Scarpignato C, Sacchi D, Oblitas WJ, Naccarato AG. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. Helicobacter 2019; e12571.

3. Kim N, Park YS, Cho SI, Lee HS. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter. 2008; 13: 245-255.

4. Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020.

5. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS‐CoV‐2. Gastroenterology 2020

6. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 2010; 139: 1894-1901.

7. W Jedrychowski 1, T Popiela, M Drews et al. Effect of Helicobacter Pylori Infection, Smoking and Dietary Habits on the Occurrence of Antrum Intestinal Metaplasia. Clinico-epidemiological Study in Poland. Pol J Pathol 1999; 50: 289-295.

8. Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest Endosc 2016; 84: 18-28.

9. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis. Int J Infect Dis 2020; 94: 91-95.

10. Young-Eun Joo, Hyun-Kyung Park, Dae-Seong Myung, et al. Prevalence and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia: A Nationwide Multicenter Prospective Study in Korea. Gut Liver 2013; 7: 303-310.

11. Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K.COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 2020; 24: 2006-2011.

12. Zhang JJ, Dong X, Cao YY et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020

13. Hung IF, Cheng VC, Wu AK et al. Viral loads in clinical specimens and SARS manifestations. Emerg. Infect. Dis 2004; 10: 1550-1557.

14. Zhou, P., et al., Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv, 2020: doi: 2020.01.22.914952.

15. Huang Q, Herrmann A. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (COVID-19). Preprint. Posted online February 04, 2020. bioRxiv 930537

16. Chu, Mei and Xu, Jiabin and Zhong, Fan and Tan, Xinghua and Tang, Guofang and Mai, Jianbo and Lai, Niangmei and Guan, Chenyu and Liang, Yujie and Liao, Gui-qing, Digestive Symptoms of COVID-19 and High Expression of ACE2 in Digestive Tract Organs (4/7/2020). Available at SSRN: https://ssrn.com/abstract=3572849

17. Chai XQ, Hu LF, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after COVID-19 infection. Preprint. Posted online February 03, 2020. bioRxiv 931766.

18. Leung WK, To KF, Chan PK et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003; 125: 1011-1017.

19. Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study Daniel E. Freedberg, MD, MS, Joseph Conigliaro, MD, MPH, Timothy C. Wang, MD, Kevin J. Tracey, MD, Michael V. Callahan, MD, Julian A. Abrams, MD, MS, on behalf of the Famotidine Research Group Famotidine Research Group, Magdalena E. Sobieszczyk, MD, MPH, David D. Markowitz, MD, Aakriti Gupta, MD, MS, Max R. O’Donnell, MD, MPH, Jianhua Li, MD, David A. Tuveson, MD, PhD, Zhezhen Jin, PhD, William C. Turner, MD, Donald W. Landry, MD, PhD. https://doi.org/10.1053/j.gastro.2020.05.053